Julian Harrison
Recent Articles about Protagonist Therapeutics Inc.
New Psoriasis Drug Shown More Effective Than On-Market One 07/06/2023
Recent clinical trial results show the oral interleukin-23 receptor to be a "cleaner" target than non-receptor tyrosine kinase 2, noted a BTIG report.
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
